1. Home
  2. BBIO vs MSA Comparison

BBIO vs MSA Comparison

Compare BBIO & MSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • MSA
  • Stock Information
  • Founded
  • BBIO 2015
  • MSA 1914
  • Country
  • BBIO United States
  • MSA United States
  • Employees
  • BBIO N/A
  • MSA N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • MSA Industrial Specialties
  • Sector
  • BBIO Health Care
  • MSA Health Care
  • Exchange
  • BBIO Nasdaq
  • MSA Nasdaq
  • Market Cap
  • BBIO 5.6B
  • MSA 6.5B
  • IPO Year
  • BBIO 2019
  • MSA N/A
  • Fundamental
  • Price
  • BBIO $36.85
  • MSA $158.44
  • Analyst Decision
  • BBIO Strong Buy
  • MSA Strong Buy
  • Analyst Count
  • BBIO 12
  • MSA 5
  • Target Price
  • BBIO $52.27
  • MSA $197.00
  • AVG Volume (30 Days)
  • BBIO 2.7M
  • MSA 132.7K
  • Earning Date
  • BBIO 02-20-2025
  • MSA 02-12-2025
  • Dividend Yield
  • BBIO N/A
  • MSA 1.30%
  • EPS Growth
  • BBIO N/A
  • MSA 387.16
  • EPS
  • BBIO N/A
  • MSA 7.21
  • Revenue
  • BBIO $221,902,000.00
  • MSA $1,808,140,000.00
  • Revenue This Year
  • BBIO $2,306.75
  • MSA $4.69
  • Revenue Next Year
  • BBIO N/A
  • MSA $3.75
  • P/E Ratio
  • BBIO N/A
  • MSA $22.05
  • Revenue Growth
  • BBIO 2285.27
  • MSA 1.15
  • 52 Week Low
  • BBIO $21.62
  • MSA $153.79
  • 52 Week High
  • BBIO $39.47
  • MSA $200.61
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 63.77
  • MSA 37.96
  • Support Level
  • BBIO $35.36
  • MSA $156.23
  • Resistance Level
  • BBIO $39.47
  • MSA $166.28
  • Average True Range (ATR)
  • BBIO 1.93
  • MSA 3.13
  • MACD
  • BBIO 0.26
  • MSA -0.58
  • Stochastic Oscillator
  • BBIO 70.79
  • MSA 21.76

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. MSA Safety generates majority of its revenue in North America. The company's reportable geographic segments are Americas, International and Corporate.

Share on Social Networks: